Jameel Clinic at MIT and KFSH&RC launch pioneering AI early breast cancer detection tool in Saudi Arabia

The MIT Jameel Clinic and the King Faisal Specialist Hospital and Research Centre (KFSH&RC) partner to bring MIT Jameel Clinic's AI technology for early detection of breast cancer, Mirai, to Saudi Arabia as KFSH&RC joins the Jameel Clinic Hospital Network. The partnership aims to enhance patient care, improve outcomes and reduce healthcare costs by leveraging AI tools and solutions in healthcare.


The Jameel Clinic, the epicentre of artificial intelligence (AI) in healthcare at the Massachusetts Institute of Technology (MIT), and King Faisal Specialist Hospital and Research Centre (KFSH&RC) have joined forces to roll out Mirai, a pioneering AI tool that can detect breast cancer up to five years earlier, and more accurately, than current mainstream screening techniques.

The introduction of the tool for the first time to the Kingdom of Saudi Arabia comes through the partnership between the Jameel Clinic and KFSH&RC. Through this collaboration the Jameel Clinic and KFSH&RC aim to deploy AI-enabled health technologies to help save lives and to revolutionise the landscape of healthcare in the kingdom, especially in breast cancer care, whose chances of treatment can double with early detection.

The Jameel Clinic, co-founded by MIT and Community Jameel in 2018, has collaborated with KFSH&RC in using artificial intelligence to deploy other innovative tools, including for the early detection of lung cancer. These tools are undergoing a number of tests on a wide range of patients under the supervision of specialist doctors to ensure that systematic health results are produced in a scientifically accurate manner.